Treating Post-Lyme Disease Syndrome With Acetogenins
Using ReaLife+ to Treat Post-Lyme Disease Syndrome
1 other identifier
interventional
30
1 country
1
Brief Summary
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jul 2019
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 31, 2019
CompletedFirst Posted
Study publicly available on registry
September 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2020
CompletedFebruary 11, 2020
February 1, 2020
5 months
August 31, 2019
February 8, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Blood test
Western Blot showing "negative"
3 months
PROMIS Fatigue Scale
Self reported fatigue level changes as measured by the Patient-Reported Outcomes Measurement Information System, Fatigue Scale.
3 months
Study Arms (3)
ReaLife+ (RLP)
ACTIVE COMPARATORDietary Supplement: ReaLife+ (RLP) RLP is a dietary supplement containing Acetogenins, vitamin, mineral and amino acids
Inert Brown Powder
PLACEBO COMPARATORBrown powder Inert brown powder to look similar to RLP
Control
NO INTERVENTIONControl
Interventions
RLP is a dietary supplement containing Acetogenins, vitamin, mineral and amino acids.
Eligibility Criteria
You may qualify if:
- A positive Western Blot for Lyme Disease that has been treated with antibiotics but the symptoms persist post treatment.
- Must be able to swallow and mixed powder drink.
You may not qualify if:
- Non Positive Western Blot test.
- Positive Western Blot test where the indivual has not been treated with antibiotics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Optimal Health Research
Salt Lake City, Utah, 84117, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dr Jeppsen, MD
IRB Chair
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2019
First Posted
September 6, 2019
Study Start
July 1, 2019
Primary Completion
November 14, 2019
Study Completion
January 30, 2020
Last Updated
February 11, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share